Member Article

Stem cell firm develops revolutionary technology

A North East bioscience company is set to take its new cell culture technology to the next level. Reinnervate, a spin out company from Durham University, was established in 2002 to commercialise research in cell biology. Earlier this year, the firm announced it had developed a new technology for growing stem cells in the laboratory.

This technology allows cells to be cultivated in realistic three dimensional conditions closer to the way cells are grown in tissues within the human body, rather than the traditional flat surface of a Petri dish used in most research laboratories.

Presently, a large proportion of new medical drugs fail in the testing stage and this new method will allow scientists to carry out drug development more accurately, and consequently reduce the number of tests carried out on animals. Reinnervate will also explore possible custom made designs to meet market demand.

Dr Stefan Przyborski, Director and Chief Scientific Officer from Reinnervate, said: “We were delighted to receive this funding from One NorthEast as it will allow us to continue building the business and fulfil our ambition of taking the product to market.”

Will Adams, Senior R&D Finance Manager from One NorthEast, said: “The North East is already recognised as having world class expertise in stem cell research, and work carried out in our local universities and in spin out companies such as Reinnervate could have a major impact in the fight against diseases in future decades.”

For more on Reinnervate, visit www.reinnervate.com.Â

This was posted in Bdaily's Members' News section by Ruth Mitchell .